MedPath
FDA Product

Pramipexole Dihydrochloride

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Pramipexole Dihydrochloride

62332-160

Regulatory Information

62332-160

ANDA204518

C73584

July 6, 2023

USA

These highlights do not include all the information needed to use PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED-RELEASE TABLETS. PRAMIPEXOLE DIHYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1997

Human Prescription Drug Label

12

Company Information

079288842

Active Ingredients

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

PRAMIPEXOLE DIHYDROCHLORIDE

Quantity: 3.75 mg in 1 1

Code: 3D867NP06J

Class Code: ACTIB

BETADEX

Code: JV039JZZ3A

Class Code: IACT

ETHYLCELLULOSE (10 MPA.S)

Code: 3DYK7UYZ62

Class Code: IACT

HYPROMELLOSE 2208 (15000 MPA.S)

Code: Z78RG6M2N2

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

Active Moieties

PRAMIPEXOLE

Code: 83619PEU5T

© Copyright 2025. All Rights Reserved by MedPath